Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
High Times Holdings is a diversified media and consumer products company that serves as a central hub for the global cannabis industry. Established in 1974 with the founding of High Times magazine, the company has evolved from a counterculture publication into a multi-faceted brand encompassing events, digital media, and retail operations. Its portfolio includes the iconic Cannabis Cup competition and a network of retail dispensaries across California. In 2023, the company entered a strategic agreement to sell its core intellectual property to Lucy Scientific Discovery, a Nasdaq-listed psychotropic drug developer, in exchange for a significant equity stake. This transaction aims to monetize the High Times brand globally while allowing the holding company to maintain its plant-touching retail and cultivation assets. High Times Holdings continues to be a major influence in the cannabis sector, bridging the gap between lifestyle media and the emerging legal marketplace.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on High Times Holdings.